The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Use of gene expression patterns post neoadjuvant chemotherapy to identify a role for the MAPK phosphatase DUSP4 in therapeutic resistance and a stem-like phenotype in basal-like breast cancer (BLBC).
J. M. Balko
No relevant relationships to disclose
R. S. Cook
No relevant relationships to disclose
T. W. Miller
No relevant relationships to disclose
N. E. Bhola
No relevant relationships to disclose
M. Sanders
No relevant relationships to disclose
N. M. Granja-Ingram
No relevant relationships to disclose
V. Sanchez
No relevant relationships to disclose
I. M. Meszoely
No relevant relationships to disclose
J. Salter
No relevant relationships to disclose
M. Dowsett
No relevant relationships to disclose
K. Stemke-Hale
No relevant relationships to disclose
A. M. Gonzalez-Angulo
No relevant relationships to disclose
G. B. Mills
No relevant relationships to disclose
C. L. Arteaga
No relevant relationships to disclose